Rilpivirine
180px | |
180px | |
Systematic (IUPAC) name | |
---|---|
4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile
|
|
Clinical data | |
Trade names | Edurant |
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a611037 |
Licence data | US FDA:link |
Pregnancy category |
|
Legal status |
|
Routes of administration |
Oral |
Pharmacokinetic data | |
Biological half-life | 38 hours |
Identifiers | |
CAS Number | 500287-72-9 ![]() |
ATC code | J05AG05 (WHO) |
PubChem | CID: 6451164 |
ChemSpider | 4953643 ![]() |
UNII | FI96A8X663 ![]() |
ChEBI | CHEBI:68606 ![]() |
ChEMBL | CHEMBL175691 ![]() |
NIAID ChemDB | 169030 |
PDB ligand ID | T27 (PDBe, RCSB PDB) |
Chemical data | |
Formula | C22H18N6 |
Molecular mass | 366.42 g/mol |
|
|
![]() ![]() |
Rilpivirine (TMC278, trade name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection.[1][2] It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.[3][4]
Rilpivirine entered phase III clinical trials in April 2008,[5][6] and was approved for use in the United States in May 2011.[7] A fixed-dose drug combining rilpivirine with emtricitabine and tenofovir, was approved by the U.S. Food and Drug Administration in August 2011 under the brand name Complera;[8] it was licensed in the European Union under the brand name Eviplera in November 2011.[9]
Like etravirine, a second-generation NNRTI approved in 2008, rilpivirine is a diarylpyrimidine (DAPY). Rilpivirine in combination with emtricitabine and tenofovir has been shown to have higher rates of virologic failure than Atripla in patients with baseline HIV viral loads greater than 100,000 copies/mm3.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Non-nucleoside reverse transcriptase inhibitors
- Nitriles
- Pyrimidines
- Belgian inventions
- Antiinfective agent stubs